Alt Üriner Sistem Nöromusküler Disfonksiyonu
Özet
Referanslar
Fowler, C.J., D. Griffiths, and W.C. De Groat, The neural control of micturition. Nature Reviews Neuroscience, 2008. 9(6): p. 453-466.
Panicker, J.N., M. De Sèze, and C.J. Fowler, Neurogenic lower urinary tract dysfunction, in Handbook of clinical neurology. 2013, Elsevier. p. 209-220.
Gajewski, J.B. and M.J. Drake, Neurological lower urinary tract dysfunction essential terminology. Neurourology and Urodynamics, 2018. 37(S6): p. S25-S31.
Tudor, K.I., R. Sakakibara, and J.N. Panicker, Neurogenic lower urinary tract dysfunction: evaluation and management. Journal of neurology, 2016. 263: p. 2555-2564.
Panicker, J.N., C.J. Fowler, and T.M. Kessler, Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. The Lancet Neurology, 2015. 14(7): p. 720-732.
McAninch, J.W. and T.F. Lue, Smith and Tanagho's general urology. 2020(Neurogenic Bladder): p. 473-483.
Panfili, Z., M. Metcalf, and T.L. Griebling, Contemporary evaluation and treatment of poststroke lower urinary tract dysfunction. Urologic Clinics, 2017. 44(3): p. 403-414.
Bizovičar, N., Managing of lower urinary tract dysfunction following stroke. Current Bladder Dysfunction Reports, 2018. 13: p. 125-131.
Gupta, A., et al., Urodynamics post stroke in patients with urinary incontinence: Is there correlation between bladder type and site of lesion? Annals of Indian Academy of Neurology, 2009. 12(2): p. 104-107.
Han, K.-S., et al., Comparison of urodynamics between ischemic and hemorrhagic stroke patients; Can we suggest the category of urinary dysfunction in patients with cerebrovascular accident according to type of stroke? Neurourology and Urodynamics, 2010. 29(3): p. 387-390.
Na, H.R. and S.T. Cho, Relationship between lower urinary tract dysfunction and dementia. Dementia and Neurocognitive Disorders, 2020. 19(3): p. 77.
Sakakibara, R., et al., Dementia and lower urinary dysfunction: With a reference to anticholinergic use in elderly population. International Journal of Urology, 2008. 15(9): p. 778-788.
Mori, S., et al., Bladder dysfunction in dementia patients showing urinary incontinence: evaluation with cystometry and treatment with propiverine hydrochloride. Nihon Ronen Igakkai zasshi. Japanese Journal of Geriatrics, 1999. 36(7): p. 489-494.
Winge, K., Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders. Handbook of clinical neurology, 2015. 130: p. 335-356.
Badri, A.V., et al., A review of lower urinary tract symptoms in patients with Parkinson’s disease. Current urology reports, 2014. 15: p. 1-9.
Berger, Y., et al., Urodynamic findings in Parkinson’s disease. The Journal of urology, 1987. 138(4): p. 836-838.
Ransmayr, G., et al., Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology, 2008. 70(4): p. 299-303.
Li, F.-F., et al., Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis. Frontiers in Aging Neuroscience, 2022. 14: p. 977572.
de Sèze, M., et al., The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler, 2007. 13(7): p. 915-28.
Tornic, J. and J.N. Panicker, The management of lower urinary tract dysfunction in multiple sclerosis. Current neurology and neuroscience reports, 2018. 18: p. 1-11.
Ineichen, B.V., et al., High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis. Multiple Sclerosis Journal, 2018. 24(4): p. 529-534.
Al Dandan, H.B., S. Coote, and D. McClurg, Prevalence of lower urinary tract symptoms in people with multiple sclerosis: a systematic review and meta-analysis. International journal of MS care, 2020. 22(2): p. 91-99.
Dodd, W., et al., Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going. J Mens Health, 2022. 18(1): p. 24.
Stoffel, J.T., Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Translational andrology and urology, 2016. 5(1): p. 127.
Schurch, B., C. Tawadros, and S. Carda, Dysfunction of lower urinary tract in patients with spinal cord injury. Handbook of clinical neurology, 2015. 130: p. 247-267.
Pavese, C. and T.M. Kessler, Prediction of lower urinary tract, sexual, and bowel function, and autonomic dysreflexia after spinal cord injury. Biomedicines, 2023. 11(6): p. 1644.
Hu, H.Z., N. Granger, and N. Jeffery, Pathophysiology, clinical importance, and management of neurogenic lower urinary tract dysfunction caused by suprasacral spinal cord injury. Journal of Veterinary Internal Medicine, 2016. 30(5): p. 1575-1588.
Berry, M., A. Juorio, and I. Paterson, The functional role of monoamine oxidases A and B in the mammalian central nervous system. Progress in neurobiology, 1994. 42(3): p. 375-391.
Gitelman, A., et al., Cauda equina syndrome: a comprehensive review. Am J Orthop (Belle Mead NJ), 2008. 37(11): p. 556-62.
Podnar, S. and D.B. Vodušek, Lower urinary tract dysfunction in patients with peripheral nervous system lesions. Handbook of Clinical Neurology, 2015. 130: p. 203-224.
Drake, M.J., Management and rehabilitation of neurologic patients with lower urinary tract dysfunction. Handbook of Clinical Neurology, 2015. 130: p. 451-468.
National Clinical Guideline, C., National Institute for Health and Clinical Excellence: Guidance, in Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease. 2012, Royal College of Physicians (UK) Copyright © 2012, National Clinical Guideline Centre.: London.
Blok, B., et al., EAU Guidelines on Neuro. Urology, 2015.
Kavanagh, A., et al., Canadian urological association guideline: diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction–full text. Canadian Urological Association Journal, 2019. 13(6): p. E157.
Gobbi, C., et al., Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Multiple Sclerosis Journal, 2011. 17(12): p. 1514-1519.